找不到产品?留下需求帮您找
一键询价梅里埃 10400奈瑟氏球菌嗜血菌鉴定盒API NH
两周
面议
梅里埃 API氧化酶试剂
两周
面议
CCFSTTG1 人脑星形细胞瘤 QCH828
一周
3500¥
MM28 人眼葡萄膜黑色瘤細胞 QCH829
一周
5500¥
HCC202 人乳腺原发性导管癌 QCH830
一周
3000¥
HCC2157 人乳腺导管癌细胞(三阴性)QCH831
一周
5000¥
hCMEC/D3-RFP红色荧光蛋白标记的人脑微血管内皮细胞 QCH346R
一周
3500¥
KHYG-1 人NK细胞淋巴瘤细胞 QCH833
一周
3500¥
NCI-h1869 人非小细胞肺癌鳞癌细胞 QCH834
一周
3500¥
NCI-H1417 人小细胞肺癌细胞 QCH835
钦诚生物 | 一周
3500¥
公告提醒:爱必信所有产品和服务仅用于科学研究,不用于临床应用及其他用途提供产品和服务(也不为任何个人提供产品和服务)!
抑制剂描述: 产品名称:CHIR-124 产品别名:见爱必信官网 英文别名:CHIR-124 靶点:Chk CAS:405168-58-3 纯度:99% 外观:见爱必信官网 保存方法:﹣20 ℃冷藏长期储存。冰袋运输 描述: CHIR-124是高活性的Chk1抑制剂,IC50为0.3 nM,比对Chk2,CDK2/4和Cdc2的抑制性高2000倍,500倍和5000倍 溶解性:DMSO:7 mg/mL 体外研究: CHIR-124 is a quinolone-based small molecule that is structurally unrelated to other known inhibitors of Chk1. CHIR-124 interacts synergistically with topoisomerase poisons (e.g., Camptothecin or SN-38) in causing growth inhibition in a variety of cancer cell lines, including breast carcinoma (MDA-MB-231 and MDA-MB-435) and colon carcinoma (SW-620 and Colo205), all of which contains the mutant p53 gene. CHIR-124 abrogates the SN-38-induced S and G2-M checkpoints and potentiates apoptosis in MDA-MD-435 breast cancer cells. The abrogation of the G2-Mcheckpoint and induction of apoptosis by CHIR-124 are enhanced by the loss of p53. CHIR-124 also potently targets other kinases such as PDGFR and Flt3 with IC50 of 6.6 nM and 5.8 nM, respectively. 体内研究:CHIR-124 potentiates the growth inhibitory effects of Irinotecan by abrogating the G2-M checkpoint and increasing tumor apoptosis in an orthotopic breast cancer xenograft model.
产品信息订购:
|